Liver fibrosis is typically triggered by alterations in these liver cells, therefore, therapeutic interventions for liver fibrosis primarily target HSCs, hepatocytes, KCs, and LSECs (Liu et al., 2024). The gene discussed is TBCE; the disease is Hepatic fibrosis.